About: AZD1305

An Entity of Type: person, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

AZD1305 is an experimental drug candidate that is under investigation for the management and reversal of cardiac arrhythmias, specifically atrial fibrillation and flutter. In vitro studies have shown that this combined-ion channel blocker inhibits rapidly the activating delayed-rectifier potassium current (IKr), L-type calcium current, and inward sodium current (INa).

Property	Value
dbo:abstract	AZD1305 is an experimental drug candidate that is under investigation for the management and reversal of cardiac arrhythmias, specifically atrial fibrillation and flutter. In vitro studies have shown that this combined-ion channel blocker inhibits rapidly the activating delayed-rectifier potassium current (IKr), L-type calcium current, and inward sodium current (INa). (en)
dbo:iupacName	2-Methyl-2-propanyl (2-{7-[2-(4-cyano-2-fluorophenoxy)ethyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}ethyl)carbamate (en)
dbo:thumbnail	wiki-commons:Special:FilePath/AZD-1305.svg?width=300
dbo:wikiPageID	35010468 (xsd:integer)
dbo:wikiPageLength	7906 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1035454596 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Cardiac_arrhythmia dbr:In_vitro dbr:In_vivo dbr:HERG dbc:Tert-butyl_compounds dbr:Atrial_flutter dbr:Atrial_fibrillation dbc:Drugs_acting_on_the_cardiovascular_system
dbp:imagefile	AZD-1305.svg (en)
dbp:imagesize	200 (xsd:integer)
dbp:iupacname	2 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Chembox dbt:Chembox_Hazards dbt:Chembox_Identifiers dbt:Chembox_Properties dbt:Reflist dbt:Cascite dbt:Fdacite
dcterms:subject	dbc:Tert-butyl_compounds dbc:Drugs_acting_on_the_cardiovascular_system
gold:hypernym	dbr:Candidate
rdf:type	owl:Thing dbo:Person dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q11173 yago:WikicatMolecularFormulas yago:Abstraction100002137 yago:Agent114778436 yago:CausalAgent100007347 yago:Communication100033020 yago:Drug103247620 yago:Formula106816935 yago:Matter100020827 yago:Message106598915 yago:MolecularFormula106817173 yago:PhysicalEntity100001930 dbo:ChemicalCompound yago:Statement106722453 yago:Substance100020090 yago:WikicatDrugsActingOnTheCardiovascularSystem
rdfs:comment	AZD1305 is an experimental drug candidate that is under investigation for the management and reversal of cardiac arrhythmias, specifically atrial fibrillation and flutter. In vitro studies have shown that this combined-ion channel blocker inhibits rapidly the activating delayed-rectifier potassium current (IKr), L-type calcium current, and inward sodium current (INa). (en)
rdfs:label	AZD1305 (en)
owl:sameAs	freebase:AZD1305 yago-res:AZD1305 wikidata:AZD1305 dbpedia-sh:AZD1305 dbpedia-sr:AZD1305 https://global.dbpedia.org/id/4K5mN
prov:wasDerivedFrom	wikipedia-en:AZD1305?oldid=1035454596&ns=0
foaf:depiction	wiki-commons:Special:FilePath/AZD-1305.svg
foaf:isPrimaryTopicOf	wikipedia-en:AZD1305
is dbo:wikiPageRedirects of	dbr:C22H31FN4O4 dbr:AZD-1305
is dbo:wikiPageWikiLink of	dbr:Potassium_channel_blocker dbr:C22H31FN4O4 dbr:AZD-1305
is foaf:primaryTopic of	wikipedia-en:AZD1305